🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of TAK-875...
Status
Terminated
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01647542
Treatments Being Tested
The purpose of this study is to evaluate the effect of TAK-875 (fasiglifam)...
Status
Terminated
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01829464
The purpose of this study is to evaluate the efficacy of fasiglifam (TAK-87...
Status
Terminated
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01834274
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of treatme...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01585792
Treatments Being Tested
The purpose of this study is to demonstrate no excess risk of cardiovascula...
Status
Terminated
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01609582
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of TAK-87...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01414920
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of multip...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01007097
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00949091
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of 2 doses of TAK-875...
Status
Terminated
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01549964
Treatments Being Tested
To evaluate the efficacy of fasiglifam 25 mg twice daily (BID) and fasiglif...
Status
Terminated
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01982253
Treatments Being Tested